Roche Is Joining The Obesity Party But Questions Remain
cagkansayin/iStock via Getty Images Roche Holding (OTCQX:RHHBY) announced positive topline results from the phase 1b trial of its obesity candidate CT-388 this week and its share price received a 4% boost on the day of the announcement. The results …